Naloxone: Opioid Overdose Response, Safety and Recovery After an Emergency

Naloxone is an opioid antagonist used to rapidly reverse the life-threatening effects of opioid overdose, especially slowed breathing. Nasal sprays and injectable preparations are available, with products and access arrangements differing by country. Narcan and Nyxoid are brand examples. Use the instructions for the actual rescue product rather than assuming every device works the same way. [1] [2]

It is useful to learn the device before an emergency. Ask a pharmacist, clinician or local overdose-prevention service to demonstrate the product and explain when another dose may be needed. Knowing the name of the medicine is not the same as knowing where it is stored or how to open and use it under pressure.

Important signs include inability to wake or respond and slow, shallow or stopped breathing. A person may look profoundly sleepy rather than obviously distressed. Do not assume they can safely sleep it off. When opioid exposure is possible, use available naloxone and obtain emergency help rather than waiting to confirm the exact substance. [3]

Tell the dispatcher what you can observe, your location and any known medicines or substances. You do not need a complete history before calling. If someone else is present, one person can call while another gives the rescue medicine. Do not delay help while searching for a packet, arguing about what was taken or deciding whether the overdose was intentional.

Give the rescue product as directed. If normal breathing does not return or symptoms recur, another dose may be required, commonly after two to three minutes for nasal products; follow the specific product instructions and dispatcher advice. If breathing is absent or abnormal, follow emergency guidance for CPR or rescue breathing. If the person is breathing normally but unconscious, the dispatcher may advise positioning them on their side. [1]

Stay with the person and keep observing breathing until emergency assistance takes over. Do not give alcohol, food, drink or more opioids to someone who is drowsy or recovering from an overdose. Avoid assuming that waking up ends the danger. Keep used devices or packaging available for clinicians when practical, but do not let this distract from breathing support and emergency communication.

Naloxone’s action can wear off before the opioid’s effects have ended, so breathing problems can return. More than one dose may be needed, including with potent or long-acting opioids. Other substances or medical complications may also be present. A response to naloxone does not establish that the person is safe to remain without observation. [2]

Explain this calmly if the person wakes and wants to leave. Encourage them to stay for emergency assessment and follow the dispatcher’s instructions. Do not make promises about how long the medicine will protect them. The appropriate observation and treatment depend on the clinical situation, not a universal period that can be selected from a website.

Naloxone reverses opioid effects; it does not reverse every cause of unconsciousness or overdose. It does not specifically treat benzodiazepine-only or stimulant-only poisoning. However, an unknown or mixed exposure may include an opioid, so possible opioid overdose remains a reason to use available naloxone while emergency care is arranged. Persistent symptoms require further assessment. [2]

Do not use a lack of response to diagnose the substance or to decide that emergency help is unnecessary. Follow instructions about repeat doses and resuscitation. Tell the emergency team about alcohol, sedatives, stimulants and prescribed medicines when known. A mixed overdose can involve several problems at once, and naloxone is one part of the response rather than a complete treatment for all of them.

In someone physically dependent on opioids, naloxone can cause sudden withdrawal. Symptoms may include restlessness, sweating, nausea, vomiting, diarrhea or body aches. These effects can be distressing, but fear of withdrawal should not delay naloxone when an overdose is suspected. Restoring breathing takes priority. [3]

Explain what is happening in a calm, nonjudgmental way and keep the person under emergency observation. Do not offer more opioids to relieve the discomfort or assume that their distress proves they have recovered safely. Tell clinicians about vomiting, agitation or other symptoms. They can assess withdrawal alongside the risk that the original opioid effect will return.

Naloxone should not be used to deliberately provoke opioid withdrawal as an improvised detox method. Its role in this guide is emergency overdose reversal. It is also not taken before opioid use as reliable protection against an overdose. Rescue medication availability does not make opioid use or sedative combinations safe. [4]

Planned opioid treatment involves a different assessment. Evidence-based medications such as buprenorphine, methadone and naltrexone may have roles in ongoing care, depending on the person. CDC advises against detoxification alone without medication treatment for opioid use disorder because return to use and overdose remain risks. [5] An emergency should open a route to further treatment, not be mistaken for completion of treatment.

Naloxone and naltrexone have similar-looking names but different uses. Naltrexone is used in ongoing addiction treatment rather than as the usual take-home emergency rescue product. Naloxone is also included in some buprenorphine combination formulations; those tablets or films are not a substitute for an overdose-rescue spray or injection. Ask a pharmacist to clarify which product you have. [2] [5]

Label the rescue kit clearly and ensure that someone helping you knows which item to use. Do not improvise a nasal or injectable dose from a tablet. The product instructions are specific to its intended route. Keeping different medicines in their original packaging reduces confusion during an urgent situation.

FDA recommends discussing naloxone when prescribing opioid pain medicines or medication for opioid use disorder, with particular attention to overdose risk and possible accidental exposure in the household. A history of overdose, opioid use disorder or use of other sedating medicines is important to discuss. Access is also relevant outside formal prescribing when someone may encounter an opioid overdose. [3]

Ask a local pharmacist or health service how to obtain the appropriate product and training. Access rules differ between countries, so a US statement about over-the-counter sale should not be assumed to apply everywhere. A practical plan includes enough usable supplies, an understanding of repeat dosing and someone who knows where the kit is located.

Follow the product’s storage and expiry instructions. Keep naloxone accessible in an emergency, not locked away with controlled medicines where a helper cannot reach it. Opioid prescriptions themselves should be securely stored to prevent accidental ingestion or use by someone else. These are different storage priorities. [3]

Check the kit when routines change, such as travel, a move or discharge from treatment. Replace used or expired devices according to local advice. Tell trusted people where it is and ask them to review the instructions. Do not open or test a single-use device in a way that leaves it unavailable when needed. A kit that nobody can locate is less useful than one integrated into a clear emergency plan.

An overdose needs medical assessment whether it was accidental, associated with uncertain substances or connected to an intention to self-harm. Naloxone reverses opioid effects but does not treat depression, trauma, suicidal thinking or the distress experienced by the person and those around them. Ongoing mental health needs should be assessed separately from the immediate breathing emergency.

If there is current suicidal intent or an inability to stay safe, seek emergency help rather than leaving the person alone with a future appointment. After the acute crisis, ask for a coordinated assessment of substance use and mental health. Our co-occurring-needs overview describes that broader approach without replacing emergency care or determining which setting is suitable.

Surviving an overdose is an opportunity to offer evidence-based care. The conversation should include medication treatment for opioid use disorder, overdose prevention, pain care where relevant and practical support. It should not require someone to prove that they can manage withdrawal unaided before discussing treatment. [5]

Ask for a named point of contact and a clear next appointment rather than an unspecific instruction to seek help. Review what made the overdose more likely, including interruptions in treatment, other substances or accidental exposure. The aim is to improve safety and access to care, not to assign blame. Family or trusted-person involvement can be helpful when agreed by the person receiving treatment.

Should I wait to be certain an opioid was involved?

No. Suspected opioid overdose warrants available naloxone and immediate emergency help. Do not delay while trying to identify an unknown drug. [1]

Is another dose sometimes necessary?

Yes. Follow the actual rescue product and dispatcher instructions if breathing does not improve or symptoms return. Continue emergency support rather than assuming one dose always completes treatment.

Does carrying naloxone replace addiction treatment?

No. It is an emergency safety measure. Ongoing treatment has a different role and should be discussed after the immediate crisis. The medication library explains other treatment medicines without choosing one for you.

1. CDC: Naloxone and overdose response.
2. SAMHSA: Opioid overdose reversal medications.
3. FDA: Naloxone access, storage and safety discussion.
4. CDC: Naloxone frequently asked questions.
5. CDC: Opioid use disorder treatment.

Use local emergency services for suspected overdose, not an admissions inquiry. This educational guide does not replace product instructions or emergency training and does not establish that COGNIFUL provides emergency treatment.